• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
[F]ZCDD083: A PFKFB3-Targeted PET Tracer for Atherosclerotic Plaque Imaging.[F]ZCDD083:一种用于动脉粥样硬化斑块成像的靶向PFKFB3的正电子发射断层显像剂。
ACS Med Chem Lett. 2020 Feb 19;11(5):933-939. doi: 10.1021/acsmedchemlett.9b00677. eCollection 2020 May 14.
2
Targeting of vascular cell adhesion molecule-1 by 18F-labelled nanobodies for PET/CT imaging of inflamed atherosclerotic plaques.用18F标记的纳米抗体靶向血管细胞粘附分子-1用于炎症性动脉粥样硬化斑块的PET/CT成像
Eur Heart J Cardiovasc Imaging. 2016 Sep;17(9):1001-8. doi: 10.1093/ehjci/jev346. Epub 2016 Jan 22.
3
P2X7 receptor-specific radioligand F-FTTM for atherosclerotic plaque PET imaging.用于动脉粥样硬化斑块 PET 成像的 P2X7 受体特异性放射性配体 F-FTTM。
Eur J Nucl Med Mol Imaging. 2022 Jul;49(8):2595-2604. doi: 10.1007/s00259-022-05689-w. Epub 2022 Jan 20.
4
Imaging of hypoxia in mouse atherosclerotic plaques with (64)Cu-ATSM.用(64)Cu-ATSM对小鼠动脉粥样硬化斑块中的缺氧情况进行成像。
Nucl Med Biol. 2016 Sep;43(9):534-542. doi: 10.1016/j.nucmedbio.2016.05.011. Epub 2016 May 30.
5
Immuno-PET Imaging of Atherosclerotic Plaques with [Zr]Zr-Anti-CD40 mAb-Proof of Concept.用[锆]锆标记抗CD40单克隆抗体对动脉粥样硬化斑块进行免疫正电子发射断层显像——概念验证
Biology (Basel). 2022 Mar 6;11(3):408. doi: 10.3390/biology11030408.
6
Evaluation of alphavbeta3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice.评估αvβ3整合素靶向正电子发射断层显像剂18F-半乳糖-RGD用于动脉粥样硬化小鼠血管炎症成像的研究。
Circ Cardiovasc Imaging. 2009 Jul;2(4):331-8. doi: 10.1161/CIRCIMAGING.108.846865. Epub 2009 May 13.
7
Amyloid-Targeting PET Tracer [F]Flutemetamol Accumulates in Atherosclerotic Plaques.淀粉样蛋白靶向 PET 示踪剂 [F]氟替美莫在动脉粥样硬化斑块中积累。
Molecules. 2019 Mar 19;24(6):1072. doi: 10.3390/molecules24061072.
8
Selective Imaging of Matrix Metalloproteinase-13 to Detect Extracellular Matrix Remodeling in Atherosclerotic Lesions.选择性成像基质金属蛋白酶-13以检测动脉粥样硬化病变中的细胞外基质重塑。
Mol Imaging Biol. 2022 Feb;24(1):93-103. doi: 10.1007/s11307-021-01626-9. Epub 2021 Jul 6.
9
Impaired gait pattern as a sensitive tool to assess hypoxic brain damage in a novel mouse model of atherosclerotic plaque rupture.在一种新型动脉粥样硬化斑块破裂小鼠模型中,步态模式受损作为评估缺氧性脑损伤的敏感工具。
Physiol Behav. 2015 Feb;139:397-402. doi: 10.1016/j.physbeh.2014.11.047. Epub 2014 Nov 20.
10
SPECT and fluorescence imaging of vulnerable atherosclerotic plaque with a vascular cell adhesion molecule 1 single-chain antibody fragment.利用血管细胞黏附分子1单链抗体片段对易损动脉粥样硬化斑块进行单光子发射计算机断层扫描(SPECT)和荧光成像
Atherosclerosis. 2016 Nov;254:263-270. doi: 10.1016/j.atherosclerosis.2016.09.005. Epub 2016 Sep 13.

引用本文的文献

1
Uncovering atherosclerotic cardiovascular disease by PET imaging.通过 PET 成像揭示动脉粥样硬化性心血管疾病。
Nat Rev Cardiol. 2024 Sep;21(9):632-651. doi: 10.1038/s41569-024-01009-x. Epub 2024 Apr 4.
2
Programmed death of macrophages in atherosclerosis: mechanisms and therapeutic targets.动脉粥样硬化中巨噬细胞的程序性死亡:机制与治疗靶点。
Nat Rev Cardiol. 2024 May;21(5):312-325. doi: 10.1038/s41569-023-00957-0. Epub 2024 Jan 2.
3
The Role of Positron Emission Tomography in Advancing the Understanding of the Pathogenesis of Heart and Vascular Diseases.正电子发射断层扫描在推进对心脏和血管疾病发病机制理解方面的作用
Diagnostics (Basel). 2023 May 18;13(10):1791. doi: 10.3390/diagnostics13101791.
4
Imaging in experimental models of diabetes.糖尿病实验模型的影像学。
Acta Diabetol. 2022 Feb;59(2):147-161. doi: 10.1007/s00592-021-01826-3. Epub 2021 Nov 15.

本文引用的文献

1
PFKFB3-mediated endothelial glycolysis promotes pulmonary hypertension.PFKFB3 介导的内皮细胞糖酵解促进肺动脉高压。
Proc Natl Acad Sci U S A. 2019 Jul 2;116(27):13394-13403. doi: 10.1073/pnas.1821401116. Epub 2019 Jun 18.
2
Perspectives on Small Animal Radionuclide Imaging; Considerations and Advances in Atherosclerosis.小动物放射性核素成像的前景;动脉粥样硬化的考量与进展
Front Med (Lausanne). 2019 Mar 11;6:39. doi: 10.3389/fmed.2019.00039. eCollection 2019.
3
The Role of PET in Evaluating Atherosclerosis: A Critical Review.正电子发射断层扫描在动脉粥样硬化评估中的作用:批判性评价。
Semin Nucl Med. 2018 Nov;48(6):488-497. doi: 10.1053/j.semnuclmed.2018.07.001. Epub 2018 Aug 30.
4
Current and Emerging Preclinical Approaches for Imaging-Based Characterization of Atherosclerosis.基于影像学的动脉粥样硬化特征描述的当前和新兴临床前方法。
Mol Imaging Biol. 2018 Dec;20(6):869-887. doi: 10.1007/s11307-018-1264-1.
5
The Glycolytic Enzyme PFKFB3 Controls TNF-α-Induced Endothelial Proinflammatory Responses.糖酵解酶 PFKFB3 控制 TNF-α 诱导的内皮前炎症反应。
Inflammation. 2019 Feb;42(1):146-155. doi: 10.1007/s10753-018-0880-x.
6
Pharmacological strategies to inhibit intra-plaque angiogenesis in atherosclerosis.抑制动脉粥样硬化斑块内血管生成的药理学策略。
Vascul Pharmacol. 2019 Jan;112:72-78. doi: 10.1016/j.vph.2018.06.014. Epub 2018 Jun 19.
7
Intravascular Ultrasound Versus Optical Coherence Tomography for Coronary Artery Imaging - Apples and Oranges?血管内超声与光学相干断层扫描用于冠状动脉成像——不可相提并论?
Interv Cardiol. 2015 Mar;10(1):8-15. doi: 10.15420/icr.2015.10.1.8.
8
Animal models of atherosclerosis.动脉粥样硬化的动物模型。
Eur J Pharmacol. 2017 Dec 5;816:3-13. doi: 10.1016/j.ejphar.2017.05.010. Epub 2017 May 5.
9
Molecular imaging of atherosclerosis with integrated PET imaging.基于正电子发射断层显像(PET)融合成像技术的动脉粥样硬化分子影像学研究
J Nucl Cardiol. 2017 Jun;24(3):938-943. doi: 10.1007/s12350-016-0766-y. Epub 2017 Jan 11.
10
Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM) on PET imaging of atherosclerosis.欧洲核医学协会(EANM)心血管委员会关于动脉粥样硬化PET成像的立场文件。
Eur J Nucl Med Mol Imaging. 2016 Apr;43(4):780-92. doi: 10.1007/s00259-015-3259-3. Epub 2015 Dec 17.

[F]ZCDD083:一种用于动脉粥样硬化斑块成像的靶向PFKFB3的正电子发射断层显像剂。

[F]ZCDD083: A PFKFB3-Targeted PET Tracer for Atherosclerotic Plaque Imaging.

作者信息

De Dominicis Carlo, Perrotta Paola, Dall'Angelo Sergio, Wyffels Leonie, Staelens Steven, De Meyer G R Y, Zanda Matteo

机构信息

Kosterlitz Centre for Therapeutics, University of Aberdeen, AB25 2ZD Foresterhill, Aberdeen, U.K.

Laboratory of Physiopharmacology, University of Antwerp, 2610 Antwerpen, Belgium.

出版信息

ACS Med Chem Lett. 2020 Feb 19;11(5):933-939. doi: 10.1021/acsmedchemlett.9b00677. eCollection 2020 May 14.

DOI:10.1021/acsmedchemlett.9b00677
PMID:32435408
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7236280/
Abstract

PFKFB3, a glycolysis-related enzyme upregulated in inflammatory conditions and angiogenesis, is an emerging target for diagnosis and therapy of atherosclerosis. The fluorinated phenoxindazole [F] was synthesized, radiolabeled in 17 ± 5% radiochemical yield and >99% radiochemical purity, and formulated for preclinical PET/CT imaging in mice. stability analysis showed no significant metabolite formation. Biodistribution studies showed high blood pool activity and slow hepatobiliary clearance. Significant activity was detected in the lung 2 h postinjection (pi) (11.0 ± 1.5%ID/g), while at 6 h pi no pulmonary background was observed. autoradiography at 6 h pi showed significant high uptake of [F] in the arch region and brachiocephalic artery of atherosclerotic mice, and no uptake in control mice, matching plaques distribution seen by lipid staining along with PFKFB3 expression seen by immunofluorescent staining. PET scans showed higher aortic region uptake of [F] in atherosclerotic ApoEFbn1 than in control mice (0.78 ± 0.05 vs 0.44 ± 0.09%ID/g). [F] was detected in aortic arch and brachiocephalic artery of ApoE (with moderate atherosclerosis) and ApoEFbn1 (with severe, advanced atherosclerosis) mice, suggesting this tracer may be useful for the noninvasive detection of atherosclerotic plaques .

摘要

磷酸果糖激酶-2/果糖-2,6-二磷酸酶3(PFKFB3)是一种在炎症和血管生成过程中上调的糖酵解相关酶,是动脉粥样硬化诊断和治疗的新兴靶点。合成了氟化苯并异吲哚酮[F],其放射性标记的放射化学产率为17±5%,放射化学纯度>99%,并将其配制成用于小鼠临床前PET/CT成像。稳定性分析表明没有显著的代谢物形成。生物分布研究显示血池活性高且肝胆清除缓慢。注射后2小时(pi)在肺部检测到显著活性(11.0±1.5%ID/g),而在注射后6小时未观察到肺部本底。注射后6小时的放射自显影显示,[F]在动脉粥样硬化小鼠的主动脉弓区域和头臂动脉中有显著高摄取,而在对照小鼠中无摄取,这与脂质染色所见的斑块分布以及免疫荧光染色所见的PFKFB3表达相匹配。PET扫描显示,动脉粥样硬化ApoE基因敲除小鼠的主动脉区域对[F]的摄取高于对照小鼠(0.78±0.05 vs 0.44±0.09%ID/g)。在载脂蛋白E(中度动脉粥样硬化)和ApoE基因敲除小鼠(重度、晚期动脉粥样硬化)的主动脉弓和头臂动脉中检测到[F],表明该示踪剂可能有助于动脉粥样硬化斑块的无创检测。